CONKLING WILLIAM 4

What Happened
William Conkling, Chief Commercial Officer of Protara Therapeutics (TARA), had 6,008 shares withheld by the company to satisfy income tax obligations related to the vesting of restricted stock units. The withholding was recorded at $4.34 per share, for a total value of approximately $26,075. This was a tax-withholding disposition (routine), not an open-market sale or purchase.

Key Details

• Transaction date and price: June 2, 2026 — 6,008 shares withheld at $4.34 per share.
• Total value: approximately $26,075.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: Shares were withheld by the issuer to satisfy income tax obligations from RSU awards granted to the reporting person on June 2, 2025. (Footnote F1)
• Filing timeliness: Reported on June 3, 2026 for a June 2, 2026 transaction — appears timely (no late filing indicated).

Context
Tax-withholding on vested RSUs is a routine, non-discretionary disposition and does not necessarily signal insider buying or selling intent. This transaction reflects withholding to cover tax liabilities from an RSU vesting event (cashless/tax-satisfaction mechanism), not a market sale.